Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06600711 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Nitazoxanide for Treatment of Cryptosporidium in Children

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Sep 30, 2026 to Dec 30, 2026
    • Eligibility criteria expanded, about 9 words
  2. Start date: Jun 30, 2026 to Sep 30, 2026v14
  3. Start date: Apr 1, 2026 to Jun 30, 2026v13
  4. Start date: Jan 12, 2026 to Apr 1, 2026v12
  5. Start date: Nov 1, 2025 to Jan 12, 2026v11
Show 9 earlier versionsHide 9 earlier versions
  1. Start date: Sep 2025 to Nov 1, 2025v10
  2. Start date: Jul 2025 to Sep 2025v9
  3. Start date: May 2025 to Jul 2025v8
  4. Start date: Apr 2025 to May 2025v7
  5. Start date: Mar 2025 to Apr 2025v6
  6. Start date: Feb 2025 to Mar 2025v5
  7. Start date: Dec 2024 to Feb 2025v4
  8. Start date: Nov 2024 to Dec 2024v3
  9. Primary completion date: Nov 2028 to Dec 2028
    • Start date: Oct 2024 to Nov 2024
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to learn if nitazoxanide (NTZ) can treat Cryptosporidium infection in children age 6-12 months. The main questions it aims to answer are: * Does NTZ treatment of diarrheal Cryptosporidium infection lower the number of days of diarrhea? * Does NTZ treatment of diarrheal and non-diarrheal Cryptosporidium infection lower the number of days that parasites can be found in the stool? Researchers will compare NTZ to a placebo (a look-alike substance that contains no drug) to see if NTZ works to treat Cryptosporidium. Participants will: * Take NTZ or placebo for 3 days * Receive regular visits from field research assistants * Provide blood and urine samples
Trial Details
NCT Number NCT06600711
Lead Sponsor Johns Hopkins Bloomberg School of Public Health
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
Conditions
(from sponsor)		 Cryptosporidiosis
Related terms Cryptosporidiosis
Enrollment 480 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov